Artrya Pty Ltd
Pictured: AI-generated image of coronary arteries.
Project Title: Artrya is using artificial intelligence to develop a non-invasive solution which evaluates cardiac CT angiography and assesses areas of restricted blood flow in the heart within minutes.
Coronary artery disease remains the leading cause of death in Australia and worldwide. Heart attack risk and the benefits of coronary revascularisation are determined by the susceptibility of atherosclerotic plaque to rupture and the burden of restricted blood flow (ischaemia).
Using Artificial Intelligence algorithms, the project is developing a cost-effective, point-of-care solution to identify areas of restricted blood flow in the heart within minutes.
The algorithms developed will identify unique risk factors such as shear-stress, types of plaque prone to rupture and perfusion into heart muscle. By reducing analysis time from days to minutes and integrating biomarker analysis, the tool will provide clinicians with an unprecedented opportunity to practice precision medicine, improve outcomes and reduce healthcare costs.
The BMTH grant enables Artrya to clinically validate the tool, complete regulatory approvals and international quality accreditation, commercialise the product and attract further equity.
BMTH Round: Three
State: Western Australia
Project Partners: University of Western Australia & Envision Medical Imaging
- MTPConnect Grant: $987,428
- Industry Contribution: $540,000
Duration: October 2020 - May 2023
Visit Artrya for more information | Twitter: @Artrya1 | LinkedIn: Artrya